Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Diastolic dysfunction in asymptomatic hemodialysis patients in the light of the current echocardiographic guidelines

J. Malik, J. Kudlicka, A. Valerianova, L. Kovarova, T. Kmentova, J. Lachmanova,

. 2019 ; 35 (2) : 313-317. [pub] 20190227

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc19027770
E-zdroje Online Plný text

NLK ProQuest Central od 1999-02-01 do Před 1 rokem
Medline Complete (EBSCOhost) od 2009-08-01 do Před 1 rokem
Health & Medicine (ProQuest) od 1999-02-01 do Před 1 rokem

The prevalence of the left ventricular hypertrophy (LVH) is very high in end-stage renal disease treated by hemodialysis. Diastolic dysfunction is a frequent consequence and leads to the development of heart failure with preserved ejection fraction. New American/European echocardiographic guidelines for the assessment of diastolic function simplified the evaluation and were published recently. The aim of this study was to reveal if the new guidelines stratify asymptomatic hemodialysis patients by the levels of brain-natriuretic peptide (BNP). A cohort of 46 patients hemodialyzed in one center with the lack of overt heart failure, systolic dysfunction, arrhythmia or significant valvular disease were examined by echocardiography before and after a single hemodialysis and blood samples for BNP analysis were drawn at both occasions. The LVH was present in 53% of patients, concentric remodeling in another 17%. Higher indexed left ventricular mass was related to higher BNP levels (r = 0.58, p = 0.0001). Before hemodialysis, diastolic dysfunction was present in 61%: grade 1 in 25%, grade 2 in 21% and grade 3 in 8%. The higher grade of diastolic dysfunction was associated with the incremental increase of BNP. The post-dialysis echocardiography did not allow the assessment of diastolic function in as many as 37% of patients. Our study has shown that the application of the current guidelines for the assessment of diastolic function based on simple four criteria differentiate hemodialysis symptomless patients with preserved systolic function according to BNP levels. BNP levels also rose together with the left ventricular mass. The ratio E/e' medial seemed to be a better predictor of increased BNP than E/e' lateral or E/e' averaged.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19027770
003      
CZ-PrNML
005      
20220309133519.0
007      
ta
008      
190813s2019 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s10554-019-01564-2 $2 doi
035    __
$a (PubMed)30815807
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Malik, Jan $u 3rd Department of Internal Medicine, General University Hospital, First Faculty of Medicine, Charles University, U nemocnice 1, 128 08, Prague, Czech Republic. jan.malik@vfn.cz.
245    10
$a Diastolic dysfunction in asymptomatic hemodialysis patients in the light of the current echocardiographic guidelines / $c J. Malik, J. Kudlicka, A. Valerianova, L. Kovarova, T. Kmentova, J. Lachmanova,
520    9_
$a The prevalence of the left ventricular hypertrophy (LVH) is very high in end-stage renal disease treated by hemodialysis. Diastolic dysfunction is a frequent consequence and leads to the development of heart failure with preserved ejection fraction. New American/European echocardiographic guidelines for the assessment of diastolic function simplified the evaluation and were published recently. The aim of this study was to reveal if the new guidelines stratify asymptomatic hemodialysis patients by the levels of brain-natriuretic peptide (BNP). A cohort of 46 patients hemodialyzed in one center with the lack of overt heart failure, systolic dysfunction, arrhythmia or significant valvular disease were examined by echocardiography before and after a single hemodialysis and blood samples for BNP analysis were drawn at both occasions. The LVH was present in 53% of patients, concentric remodeling in another 17%. Higher indexed left ventricular mass was related to higher BNP levels (r = 0.58, p = 0.0001). Before hemodialysis, diastolic dysfunction was present in 61%: grade 1 in 25%, grade 2 in 21% and grade 3 in 8%. The higher grade of diastolic dysfunction was associated with the incremental increase of BNP. The post-dialysis echocardiography did not allow the assessment of diastolic function in as many as 37% of patients. Our study has shown that the application of the current guidelines for the assessment of diastolic function based on simple four criteria differentiate hemodialysis symptomless patients with preserved systolic function according to BNP levels. BNP levels also rose together with the left ventricular mass. The ratio E/e' medial seemed to be a better predictor of increased BNP than E/e' lateral or E/e' averaged.
650    _2
$a senioři $7 D000368
650    _2
$a asymptomatické nemoci $7 D058070
650    _2
$a biologické markery $x krev $7 D015415
650    _2
$a diastola $7 D003971
650    12
$a dopplerovská echokardiografie $7 D015150
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a hypertrofie levé komory srdeční $x diagnostické zobrazování $x etiologie $x patofyziologie $7 D017379
650    _2
$a chronické selhání ledvin $x komplikace $x diagnóza $x patofyziologie $x terapie $7 D007676
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a natriuretický peptid typu B $x krev $7 D020097
650    _2
$a prediktivní hodnota testů $7 D011237
650    12
$a dialýza ledvin $x škodlivé účinky $7 D006435
650    _2
$a rizikové faktory $7 D012307
650    _2
$a tepový objem $7 D013318
650    _2
$a časové faktory $7 D013997
650    _2
$a výsledek terapie $7 D016896
650    _2
$a dysfunkce levé srdeční komory $x diagnostické zobrazování $x etiologie $x patofyziologie $7 D018487
650    12
$a funkce levé komory srdeční $7 D016277
650    _2
$a remodelace komor $7 D020257
655    _2
$a časopisecké články $7 D016428
700    1_
$a Kudlicka, Jaroslav $u 3rd Department of Internal Medicine, General University Hospital, First Faculty of Medicine, Charles University, U nemocnice 1, 128 08, Prague, Czech Republic.
700    1_
$a Valerianova, Anna $u 3rd Department of Internal Medicine, General University Hospital, First Faculty of Medicine, Charles University, U nemocnice 1, 128 08, Prague, Czech Republic.
700    1_
$a Kovarova, Lucie $u 3rd Department of Internal Medicine, General University Hospital, First Faculty of Medicine, Charles University, U nemocnice 1, 128 08, Prague, Czech Republic.
700    1_
$a Kmentová, Tereza $u 3rd Department of Internal Medicine, General University Hospital, First Faculty of Medicine, Charles University, U nemocnice 1, 128 08, Prague, Czech Republic. $7 xx0270477
700    1_
$a Lachmanova, Jana $u Department of Nephrology, General University Hospital, First Faculty of Medicine, Charles University, Prague, Czech Republic.
773    0_
$w MED00007621 $t The international journal of cardiovascular imaging $x 1875-8312 $g Roč. 35, č. 2 (2019), s. 313-317
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30815807 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190813 $b ABA008
991    __
$a 20220309133514 $b ABA008
999    __
$a ok $b bmc $g 1432919 $s 1066230
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 35 $c 2 $d 313-317 $e 20190227 $i 1875-8312 $m The international journal of cardiovascular imaging $n Int J Cardiovasc Imaging $x MED00007621
LZP    __
$a Pubmed-20190813

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...